Prosecution Insights
Last updated: April 19, 2026

Examiner: JAIPRASHAD, RAJESH

Tech Center 1600 • Art Units: 1691

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
6
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
12.5%
§102 Novelty
56.3%
§103 Obviousness
31.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18380141 METHODS FOR TREATING SPINAL MUSCULAR ATROPHY Non-Final OA Hoffmann-La Roche Inc.
18288677 KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS Non-Final OA SAMYANG HOLDINGS CORPORATION
18290377 Emulsion or Oil-Dispersion Cosmetic Composition Containing High Content of Powder Non-Final OA LG Household & Health Care Ltd.
18496199 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OCULAR DISEASE COMPRISING ENAVOGLIFLOZIN Non-Final OA DAEWOONG THERAPEUTICS INC.
18374663 A SYNTHESIS OF POTASSIUM 5,7-DINITRO-[2,1,3]-BENZOXADIAZOL-4-OLATE-3-OXIDE Non-Final OA PRIMODIA CHEMICALS AND PHARMACEUTICALS PRIVATE LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month